middle.news
ImpediMed Advances Cancer and Heart Health with $15.3m Capital Raise
8:31am on Tuesday 28th of July, 2026 AEST
•
Healthcare
Read Story
ImpediMed Advances Cancer and Heart Health with $15.3m Capital Raise
8:31am on Tuesday 28th of July, 2026 AEST
Key Points
Q4 revenue rises 3% to $3.6 million
Annual Recurring Revenue steady at $14.4 million
Capital raise of $15.3 million with partial $5 million loan repayment
Expanded US reimbursement coverage to 95% of lives
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Impedimed (ASX:IPD)
OPEN ARTICLE